Helicobacter pylori infections are usually established in early childhood and continuously stimulate immunity, including T-helper 1 (Th1), Th17, and regulatory T-cell (Treg) responses, throughout life. Although known to be the major cause of peptic ulcer disease and gastric cancer, disease occurs in a minority of those who are infected. Recently, there has been much interest in beneficial effects arising from infection with this pathogen. Published data robustly show that the infection is protective against asthma in mouse models. Epidemiological studies show that H. pylori is inversely associated with human allergy and asthma, but there is a paucity of mechanistic data to explain this. Since Th1 and Treg responses are reported to protect against allergic responses, we investigated if there were links between the human systemic Th1 and Treg response to H. pylori and allergen-specific IgE levels. The human cytokine and T-cell responses were examined using peripheral blood mononuclear cells (PBMCs) from 49 infected and 58 uninfected adult patients. Concentrations of total and allergen-specific plasma IgE were determined by ELISA and ImmunoCAP assays. These responses were analyzed according to major virulence factor genotypes of the patients' colonizing H. pylori strains. An in vitro assay was employed, using PBMCs from infected and uninfected donors, to determine the role of Treg cytokines in the suppression of IgE. Significantly higher frequencies of IL-10-secreting CD4 + CD25 hi Tregs, but not H. pylori-specific Th1 cells, were present in the peripheral blood of infected patients. Total and allergen-specific IgE concentrations were lower when there was a strong Treg response, and blocking IL-10 in vitro dramatically restored IgE responses. IgE concentrations were also significantly lower when patients were infected with CagA + strains or those expressing the more active i1 form of VacA. The systemic IL-10 + Treg response is therefore likely to play a role in H. pylori-mediated protection against allergy in humans.
Helicobacter pylori infections are usually established in early childhood and continuously stimulate immunity, including T-helper 1 (Th1), Th17, and regulatory T-cell (Treg) responses, throughout life. Although known to be the major cause of peptic ulcer disease and gastric cancer, disease occurs in a minority of those who are infected. Recently, there has been much interest in beneficial effects arising from infection with this pathogen. Published data robustly show that the infection is protective against asthma in mouse models. Epidemiological studies show that H. pylori is inversely associated with human allergy and asthma, but there is a paucity of mechanistic data to explain this. Since Th1 and Treg responses are reported to protect against allergic responses, we investigated if there were links between the human systemic Th1 and Treg response to H. pylori and allergen-specific IgE levels. The human cytokine and T-cell responses were examined using peripheral blood mononuclear cells (PBMCs) from 49 infected and 58 uninfected adult patients. Concentrations of total and allergen-specific plasma IgE were determined by ELISA and ImmunoCAP assays. These responses were analyzed according to major virulence factor genotypes of the patients' colonizing H. pylori strains. An in vitro assay was employed, using PBMCs from infected and uninfected donors, to determine the role of Treg cytokines in the suppression of IgE. Significantly higher frequencies of IL-10-secreting CD4 H. pylori Protection against Allergy Frontiers in Immunology | www.frontiersin.org inTrODUcTiOn Helicobacter pylori infection usually becomes established during early childhood (1) , when the immune system is developing, and it persists life-long in the absence of effective treatment (2) . Peptic ulceration and gastric malignancy may result; however, the infection is asymptomatic in the vast majority of cases. In recent years, there has been considerable interest in the possible beneficial effects of H. pylori infection (3) (4) (5) (6) . Protective associations between the infection and risk of atopy, asthma, and autoimmunity have been reported in epidemiological studies by us and several other groups (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) . Not all studies have been able to demonstrate such trends, however (22) (23) (24) . A meta-analysis of 700 cases and 785 controls could not prove a link between H. pylori infection and asthma risk (25) , and some researchers remain skeptical (26) . The most consistently observed protective associations with asthma and atopy, however, are in children (8, 16, 18, 20, 24, 27) .
The incidence of atopic disease in developed countries has increased markedly over the past 50 years (28, 29) . Although genetic predisposition is very important, genetic changes cannot explain this recent dramatic trend. The worldwide prevalence of H. pylori is declining, and fewer children are now infected (6, 30, 31) . In developing countries, such as India and Mexico, the infection remains present in over 80% of the population, but in many developed countries, the prevalence of H. pylori is now less than 20% and it is expected to decline further (32, 33) . A role for H. pylori in the "hygiene hypothesis" has been suggested, where childhood exposure to certain infections is needed for development of a healthy immune system (34, 35) . Modernization has diminished exposure to many of the immunoregulatory stimuli that humans have co-evolved with, including intestinal parasites, ectoparasites, environmental bacteria, gut commensal organisms, and also H. pylori (10, (35) (36) (37) (38) . It is thought that during the past 60,000 years, human physiology has developed with the continual presence of the bacterium in the stomach (6, 39) . There is growing evidence that adverse consequences may arise from a lack of exposure to H. pylori (5) .
Allergies occur more commonly when certain immunological exposures are absent. Mechanisms include the stimulation of regulatory T cell (Treg) and T-helper 1 (Th1) responses to counterbalance and suppress Th2 activity in atopy (37, 38, (40) (41) (42) . Although the epidemiological evidence for protective associations of H. pylori infection with atopy is compelling, it could be argued that the infection is simply a marker for other exposures with similar risk factors. The first indication of a causal relationship came from finding stronger links between childhood asthma and infection with more pathogenic CagA + H. pylori strains (9) . Direct proof of H. pylori-mediated protection in humans is still lacking, however. Arnold et al. were the first to demonstrate in a mouse model that H. pylori infection is protective against allergic asthma (43) . In agreement with the human epidemiological data, these effects were stronger when the mice were infected as neonates. The mechanism was demonstrated to involve dendritic cell-mediated induction of immunosuppressive regulatory T-cells (Tregs), and the H. pylori factors important in driving this include vacuolating cytotoxin A (VacA), gamma glutamyl transpeptidase (GGT), and urease (44) (45) (46) (47) .
There is a wealth of published data demonstrating that H. pylori infection induces high-level Treg, Th1, and Th17 responses in both humans and mouse models (48) (49) (50) (51) (52) (53) . Interferon-gamma (IFNγ)-secreting Th1 cells are associated with increased gastric inflammation and disease, whereas Tregs inhibiting inflammation are associated with reduced incidence of disease and probably contribute to the life-long persistence of H. pylori infections (32, 48) . They are known to be important for suppressing autoimmunity, allergy, and inflammation (54, 55) . There are several different types of Treg cells, commonly characterized as CD4 + , FOXP3 + , CD127 low , and expressing high levels of CD25 (56) . Tregs may act via a number of mechanisms, including contact-mediated suppression, or secretion of suppressive cytokines, such as interleukin-10 (IL-10), IL-35, or transforming growth factor beta (TGFβ) (57) (58) (59) . IL-10 is known to be protective against allergy, acting via inhibition of antigen presentation, down-regulation of effector T-cell cytokine expression, and inhibition of mast cell degranulation (42, (60) (61) (62) . TGFβ is also reported to play a role in protection against some animal models of allergy (63, 64) . Because of the ontogeny of the immune system, H. pylori-infected children tend to have stronger Treg responses than adults (65) (66) (67) . This aligns with stronger protection in the neonatally infected mouse allergy model (43) and also raises the hypothesis that the elevated frequencies of Tregs present in the circulation of H. pylori-infected humans (68) play an important role in protection against allergy.
While a great deal of convincing animal model data exist, it has frequently been difficult to prove protective effects of infections, including parasites, on clinical atopy and asthma (69) . For this reason, we decided to look for more subtle effects, studying the IgE responses of non-atopic, non-asthmatic patients with carefully characterized H. pylori infection status. As reported previously (68), we found higher frequencies of IL-10-secreting Tregs in the peripheral blood of infected patients. Very low plasma IgE concentrations were present in those with the highest Treg responses, but there were no associations with the Th1 response. This indicated that higher levels of H. pylori-induced Tregs are associated with reduced markers of allergy. In vitro experiments also confirmed that blocking IL-10 (but not IFNγ or TGFβ) resulted in significantly increased IgE secretion by peripheral blood mononuclear cells (PBMCs) from infected, but not uninfected, donors. These data indicate a role for H. pylori-induced IL-10-secreting Tregs in protection against human allergy.
MaTerials anD MeThODs
All reagents were obtained from Sigma-Aldrich Ltd. (Poole, UK) unless otherwise stated.
ethics statement
Clinical samples were donated with informed written consent and approval from Nottingham Research Ethics Committee 2 (reference 08/H0408/195). commonly dyspepsia), but were otherwise healthy. Out of 107 patients, 49 donors were H. pylori-positive (14 duodenal ulcer, 9 gastric ulcer, and 26 no ulceration) and 58 were negative (none had peptic ulcers). Male-to-female ratios of these groups were 0.93 and 0.70, respectively; mean ages were 59.7 and 54.6 years, respectively. None of the patients were regularly taking nonsteroidal anti-inflammatory drugs or had taken antibiotics or proton pump inhibitor drugs in the preceding 2 weeks. None had clinically diagnosed asthma or allergies.
Volunteers and clinical Materials
A series of biopsies were collected from the gastric antrum for determination of H. pylori infection status by urease detection, isolation and culture of the organism, and histopathology (48). DNA was purified from H. pylori isolates and PCR-genotyping carried out to ascertain cagA and vacA genotype status (70, 71) . The 20-ml peripheral blood samples were collected into EDTA vacutainers. Samples of plasma were separated and stored at −80°C. PBMCs were purified by density gradient centrifugation using Histopaque1077.
Quantification of Treg and Th1-associated cytokine responses of human PBMcs
Peripheral blood mononuclear cells at 1 × 10 6 /ml in AIM V medium (Invitrogen) were placed 0.2 ml/well into 96-well plates in duplicate. A H. pylori lysate antigen prepared from six clinical isolates (48) was added at 25 μg/ml. Negative controls received no antigen, whereas positive controls received 5-μg/ml concanavalin A (conA) before incubation for 48 h at 37°C in 5% CO2. Commercial ELISA kits (eBioscience, Hatfield, UK) were used to quantify IL-10 and TGFβ1 in culture supernatants, as per the manufacturer's instructions.
Quantification of Treg and Th1 cells in human PBMcs
As described previously (48, 68, 72) , 1 × 10 6 PBMCs were placed into culture tubes in RPMI1640 with 10% fetal calf serum (FCS), 100 U/ml penicillin, and 100 μg/ml streptomycin. H. pylori lysate antigen was added at 25 μg/ml, negative controls received no antigen, and positive controls received 20 ng/ml phorbol myristate acetate (PMA) and 1 μmol/l ionomycin. Brefeldin A (BFA) was added to all tubes at 10 μg/ml before 16 h incubation at 37°C in 5% CO2.
Cells were stained with anti-CD4-phycoerythrin-Texas Red (ECD; Beckman Coulter UK Ltd., High Wycombe, UK) and anti-CD25-PE-cyanin 5 (PC5; Biolegend, Cambridge BioScience Ltd., Cambridge, UK), with either anti-CD127-phycoerythrin (PE; eBioscience, San Diego, CA, USA), anti-CTLA- 
FOXP3 and IL10 rT-qPcr
The 5 × 10 6 PBMCs were purified from fresh blood samples using Histopaque 1077, and total RNA was extracted using an RNeasy minikit (QIAGEN, Crawley, UK), as per the manufacturer's instructions. cDNA was synthesized using SuperScript II reverse transcriptase with an oligo(dT) primer (Invitrogen). Real-time PCR was performed on a Rotor-Gene 3000 (Corbett Research, Cambridge, UK) using primers described in Table 1 , with a DyNAmo HS SYBR green qPCR kit (New England Biolabs, Ipswich, UK) as previously described (48) . Amplification was over 45 cycles of 15 s at 95°C, 30 s at 62°C, and 30 s at 72°C. No template controls were included in each run, and a melting curve analysis was performed. First-stage RT-qPCR samples, produced without reverse transcriptase, were assayed in parallel. Results were analyzed using the Pfaffl method (74). FOXP3 and IL10 expression levels were normalized against GAPDH, comparing to a pooled reference sample from five Hp-negative donors to obtain a fold difference. A commercial pooled human cDNA standard (BD Biosciences) was included as a positive control in all assays.
human ige assays
Plasma IgE concentrations were determined using a Human IgE ELISA Quantification Kit (Bethyl, USA) as per the manufacturer's instructions. Optical densities were measured at 450 nm with a reference wavelength of 595 nm. Concentrations of IgE were determined from a standard curve on each plate. Allergenspecific IgE assays [timothy grass pollen, birch tree pollen, and Dermatophagoides pteronyssinus (house dust mite)] were carried out by the Department of Immunology, Queen's Medical Centre, Nottingham, using the ImmunoCAP system (Phadia AB, Uppsala, Sweden). In Vitro PBMc culture and Manipulation of the cytokine response A method to induce IgE synthesis in PBMC cultures was adapted from previously published studies (75) (76) (77) . PBMCs from 5 H. pylori-positive and 10 H. pylori-negative healthy non-allergic donors were resuspended in RPMI 1640 medium (supplemented with 10% FCS, 100 U/ml penicillin, 100 μg/ml streptomycin, 50 μg/ml transferrin, and 4 μg/ml insulin). The 200-μl aliquots containing 3 × 10 5 cells were added to the wells of a sterile 96-well polystyrene round-bottomed plate (Thermo Scientific). In order to induce Th2-skewed conditions, rIL-4 and sCD40L were added to the cells at final concentrations of 50 μg/ ml and 100 ng/ml, respectively (Peprotech). The PBMCs were cultured for 12 days at 37°C and 5% CO2. Supernatants were then removed and stored at −80°C.
In order to observe the effects of IL-10 and TGFβ on IgE synthesis, on day 0 of the culture, 20-μl recombinant human IL-10 (rIL-10) (AbD Serotec) or rTGFβ (AbD Serotec) were added at various concentrations to appropriate wells in quadruplicate (76) . The equivalent volume of medium was added to control wells. Cytokines were blocked by adding anti-IL-10 (rat IgG1 clone JES3-9D7, eBioscience) and anti-TGFβ (mouse IgG1 clone 1D11, Abcam) mAbs at varying concentrations. The respective isotype control antibodies were added at the equivalent concentrations. The 20-μg/ml JES3-9D7 has previously been shown to efficiently neutralize endogenously produced IL-10 in a similar culture system (77). The neutralization dose (ND50) of 1D11 antibody is typically 0.25-1.25 μg/ml in the presence of 1 ng/ml recombinant human TGFβ1 (78) . The PBMCs were then cultured for 12 days at 37°C with 5% CO2 before collection and assay of the supernatants for IgE.
statistical analysis
Statistical analyses were carried out using Prism 6.00 (GraphPad Software, CA, USA). Since the data were not normally distributed, non-parametric analysis methods were used. Statistical tests of paired data were carried out using the Wilcoxon signed rank test. For unpaired data, the Mann-Whitney U-test was used. A significant difference was taken at p ≤ 0.05.
Box and whisker plots depict the medians and interquartile ranges in the boxes, with whiskers extending to the maximum and minimum points in the data.
resUlTs

Peripheral Blood Th1 and Treg responses in infected and Uninfected Patients
Previous work showed a high-level Treg and Th1 response in the H. pylori-infected human gastric mucosa and significantly increased numbers of CD4
hi Tregs in peripheral blood (48, 68) . We further investigated the circulating Treg population and determined if higher numbers of Th1 cells were also present. We began by quantifying the cytokines IFNγ, IL-10, and TGFβ1 in PBMC culture supernatants from infected and uninfected patients, and comparing the frequencies of Treg and Th1 cells by flow cytometry. PBMCs from all patients secreted IFNγ when stimulated with H. pylori lysate antigen (Hp) (Figure 1A) or the positive control mitogen conA; however, the concentrations were higher (median difference: 3.6-fold) among the Hp-stimulated supernatants from infected compared to uninfected individuals (p = 0.05). This is indicative of a systemic Th1 response to Hp infection. Similarly, there were slightly higher concentrations of IL-10 (median: 1.3-fold, p = 0.02), but there were no differences in TGFβ1 levels.
Using flow cytometry to quantify Hp-specific Th1 cells, we immunostained for the early activation marker CD69 (72) and analyzed cells that were activated by Hp lysate antigen ( Figure 1B) Figure 1C) , and similar statistically significant trends were found following PMA/ionomycin stimulation. No significant differences in the responses of cells from infected and uninfected donors were found; therefore, we could not confirm an increased frequency of Th1 cells in the peripheral blood of the infected patients. There were also no differences according to the cagA virulence genotype of the colonizing bacterial strains (not shown).
To quantify the Treg response, CD25 hi staining was taken as a higher intensity of fluorescence compared to that observed for CD4 negative cells (Figure 2A Figure 3C) , and FOXP3 mRNA levels were no different when assaying PBMCs by RT-qPCR ( Figure 3D ). The variation in FOXP3
+ cell frequencies was extremely wide within both the infected and the uninfected groups, which hampered our ability to detect statistically significant differences. Hp antigen resulted in a significant increase in the proportion of Tregs secreting IL-10 (p = 0.01), but there was no significant effect on cells from uninfected patients ( Figure 3E) . This indicates that H. pylori infection induces a specific IL-10-secreting peripheral blood Treg response. IL10 mRNA levels in freshly isolated PBMCs from infected patients were 3.8-fold higher than the uninfected group (p = 0.001; Figure 3F) , and there was a 4.8-fold higher mRNA level in the samples from infected patients without peptic ulcer disease compared to those who had ulcers (p = 0.017). These data confirm the presence of increased numbers of IL-10 + cells in the circulation of H. pylori-infected patients, particularly when peptic ulceration is absent. Since there was an elevated systemic IL-10-secreting Treg response in infected patients, we hypothesized that as in the mouse, this could be an important mechanism behind the protective associations with allergy.
association between the human regulatory T-cell and ige responses
Total and allergen-specific IgE concentrations in the plasma of 49 infected and 46 uninfected patients were not significantly different ( Table 2) ; however, among the infected group, there were differences in total IgE according to the virulence genotype of the colonizing H. pylori strains. This was important to evaluate, since presence of a strain expressing CagA has previously been reported to be associated with greater protection against asthma (9) . VacA is known to be protective against allergy in mice (45). Since cagA + strains usually also express the most active i1 form of vacA (71), we investigated how IgE levels related to these virulence factors. Apart from in five cases, the 29 cagA + strains were also of the more active vacA i1 type. All but 5 of the 20 less pathogenic cagA − strains were typed as having the . Among gated CD4 + CD25 hi events, the majority of IL-10 + events were also FOXP3 + (e).
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Frontiers in Immunology | www.frontiersin.org less active i2 form of vacA. We were therefore unable to pick apart the roles of these factors individually. The patients infected with the more virulent cagA + or vacA i1 strains had threefold lower concentrations of IgE compared to those with cagA − or vacA i2 strains (Figure 4 ; p = 0.005 and p = 0.029, respectively). Surprisingly, however, there were no significant differences in Treg frequencies or IL-10 transcripts between those with cagA + versus cagA -strains, and the same result was found for vacA genotypes (data not shown).
When comparing the magnitude of the Treg response with IgE levels, we observed some interesting trends. Patients with the highest frequencies of CD4 + CD25 hi PBMCs had the lowest total IgE concentrations. The effect was stronger among the samples from H. pylori-positive patients (Figures 5A,C) , where having a high-level Treg response was more common. The data were stratified according to whether or not CD4 +
CD25
hi cell frequencies were above or below 10%, which equated to the mean + 1 SD of all samples tested and was well above the normal range for frequencies of these cells in peripheral blood as previously reported in other studies (79, 80) . Among the samples from infected patients with high CD4 + CD25 hi cell frequencies, there was a fivefold lower median IgE concentration, compared to those with frequencies below 10% (p = 0.001) ( Figure 5C ). Among the samples from infected patients with high IL-10 + CD4 + CD25 hi cell frequencies (>0.4%, mean + 1 SD), similarly there was a fivefold lower median IgE concentration, compared to those with low IL-10 + Treg frequencies (p = 0.01) (Figure 5B,D) . There was no significant difference in the total plasma IgE concentrations of uninfected patients with high and low Treg frequencies (Figures 5C,D) .
A significantly reduced grass (p = 0.004) and birch (p = 0.002) pollen-specific IgE concentration was present among infected patients with high frequencies of peripheral blood Treg cells (Table 3) , but there were no significant differences among the uninfected group, or with regard to house dust mite-specific IgE. Similar trends were observed when comparing IgE concentrations with frequencies of IL-10 + CD4 + CD25 hi PBMCs (data not shown). There were no significant trends when PBMC Th1 responses were compared with IgE levels (data not shown). Together, these data indicate that H. pylori infection is associated with unusually high circulating Treg levels, which could perhaps directly or indirectly suppress IgE production and influence the development of allergy. infected (medians 25.8 and 34.2 pg/ml, respectively; p = 0.013; Figure 6A ). The concentrations of IL-10 were fivefold higher in the supernatants of PBMCs from the infected donors (p = 0.055; Figure 6B ), but there were no differences in the concentrations of TGFβ1 ( Figure 6C) . The cultures were also performed in the presence or absence of varying concentrations of recombinant IL-10, TGFβ1, or antibodies known to block the function of these cytokines. A range of concentrations was used so that we could investigate if there was a dose-response effect. Comparing each treatment to the non-treated control for each donor, the percentage decrease in total IgE resulting from the addition of recombinant cytokines was calculated. Adding the recombinant cytokines, at a range of concentrations reported previously to potently interfere with human T-helper cell activity (76, 81) , caused a dose-dependent reduction in IgE secretion by PBMCs from both H. pylori-positive and -negative donors (Figures 7A,B) . rIL-10 appeared to have a more potent effect than rTGFβ. Adding as little as 10 ng/ml rIL-10 resulted in a median 31% reduction in IgE concentration in the cultures compared to controls without rIL-10 (p = 0.020). Adding 20 ng/ml rIL-10 resulted in a median 52% reduction in IgE (p = 0.001). In contrast, a significantly reduced IgE concentration could only be achieved using the highest concentration of 100 ng/ml rTGFβ (5% reduction compared to no rTGFβ controls, p = 0.041). No differences in IgE response could be found between the PBMCs from H. pylori-positive and -negative donors in these assays however.
Adding IL-10 mAb, at a range of concentrations reported previously to block cytokine activity (77, 78) , resulted in increased IgE production by PBMCs from both groups (H. pylori-positive and -negative donors), compared to cultures with the equivalent concentration of isotype control antibodies ( Figure 7C) . Adding anti-TGFβ had very little effect ( Figure 7D) . The difference in the size of the effect from IL-10 blockade between H. pyloripositive and -negative donors was statistically significant (20 μg/ ml: 24%, p = 0.02; 40 μg/ml: 53%, p = 0.006). Therefore, we had confirmation that blocking IL-10, which was present at higher concentrations in the isotype control cultures of PBMCs from H. pylori-positive donors (Figure 6B) , had a pronounced suppressive influence on IgE production in vitro.
DiscUssiOn
This study aimed to further investigate the inverse association between H. pylori infection and allergy in humans, and fill an important gap in current literature by exploring the potential mechanisms behind this. We were able to demonstrate a link between IL-10-secreting peripheral blood Treg cell numbers and the concentration of IgE in the plasma of infected patients, and we also showed that IL-10 produced by leukocytes from those with H. pylori played an important role in controlling IgE production in vitro.
Our previous work found an increased Treg and Th1 response in the H. pylori-infected human gastric mucosa (48) and higher frequencies of Tregs in the peripheral blood of infected patients (68) . These cell types have previously been implicated in the suppression of Th2 responses and allergy. We hypothesized that increased levels of Treg cells and/or Th1 cells in the circulation 
Mechanistic experiments to investigate the role of Th1 and Treg cytokines in the suppression of ige
To test the previously observed associations between H. pylori infection, serum IgE levels and abundance of peripheral blood Treg cells, an in vitro culture system was employed. PBMCs from 5 infected and 10 uninfected healthy donors (all without ulcers) were cultured under Th2-skewing conditions [with IL-4 and rCD40L (75) ] for 12 days. Total IgE, IL-10, and TGFβ1 concentrations in the culture supernatants were then measured by ELISA. These culture conditions were used to investigate the hypothesis that PBMCs from H. pylori-positive donors would be inherently less able to respond to the Th2 stimulation compared to those from H. pylori-negative donors, possibly due to IL-10 or TGFβ inhibition of IgE production in vitro. The culture system provided an opportunity to investigate the consequence of adding or selectively blocking IL-10 and TGFβ. From the in vivo data, we hypothesized that blocking IL-10 would increase IgE production more markedly when the PBMCs were from H. pylori-positive donors. As anticipated, IgE concentrations were lower for the infected donors compared to those who were not H. pylori Protection against Allergy Frontiers in Immunology | www.frontiersin.org influence immune responses at extra-gastric sites in the body and may play a role in preventing an elevated IgE response. Initially, we compared the IFNγ, IL-10, and TGFβ1 responses of PBMCs to stimulation with Hp lysate antigen. Enhanced concentrations of IFNγ [as shown previously (82)] and IL-10 were found in the PBMC supernatants from infected patients, indicating that peripheral blood Th1 and Treg responses were increased. Cells from both H. pylori-positive and -negative patients secreted IFNγ and IL-10 in response to Hp lysate antigens, indicating that the response was not antigen specific. Flow cytometry was therefore used to determine whether increased frequencies of Th1 and Treg cells were present in the blood of infected patients.
Our experiments employed detection of CD69 expression, an early activation marker (83) , as a tool to identify IFNγ + CD4 + Th1 cells that were responsive to Hp stimulation. This could be a consequence of antigen-specific reactivation of memory cells or T-cell receptor-independent immune activation. In agreement with the work of Lundgren et al. (84) , peripheral blood CD4 + cells secreted IFNγ when stimulated with Hp antigen; however, there were no differences between the samples from infected and uninfected donors. The response is therefore unlikely to be due to reactivation of H. pylori-specific memory cells, but could arise because of shared or cross-reactive antigens with other bacteria, or because ligands for pattern recognition receptors were present in the antigen preparation (85) .
In agreement with our previous work, and that of others, we found higher levels of CD4 +
CD25
hi lymphocytes among PBMCs from the infected donors (68, 84) . It was necessary to determine if these populations could be classed as Tregs by using a selection of cellular markers, and a large proportion of the CD4 + CD25 hi events expressed FOXP3 and/or IL-10. Since enhanced FOXP3
+
Treg levels are present in the infected human gastric mucosa (48, 49, 51) , we were surprised to find no difference in the frequencies population from uninfected patients, indicating the presence of a H. pylori-specific circulating Treg response. We were also able to confirm this by RT-qPCR, where higher levels of IL10 mRNA were found in PBMCs from the infected patients. This agrees with several previous reports of H. pylori-specific IL-10-secreting CD4 + FigUre 6 | culture of PBMcs under Th2-skewing conditions. PBMCs from 5 infected and 10 uninfected donors were cultured for 12 days before assaying the supernatants for total IgE (a), IL-10 (B), and TGFβ1 (c) by ELISA. NS = no significant difference. cells in the blood (87) (88) (89) . We previously found increased levels of IL-10 + FOXP3 + Tregs in the H. pylori-infected human gastric mucosa, cellular FOXP3 expression was of high level and could be confirmed by RT-qPCR (48) . Our data suggest that slightly different Treg populations may be present in the blood, and these could include a higher proportion of FOXP3
− subtypes, such as Tr1 cells (which are IL-10 + ) (90) and FOXA1 + cells (associated with IFNβ responses) (91) , since H. pylori stimulates the production of IFNβ by gastric epithelial cells (92) . Recently, we were able to show that significantly higher proportions of peripheral blood Tregs from infected patients expressed the chemokine receptor CCR6 and that high concentrations of its ligand, CCL20, were present in infected human gastric mucosal tissue. The CCL20-CCR6 axis was shown to play an important role in the migration of Tregs to the infected gastric mucosa (68) . Some studies have suggested that CCL20/CCR6 interactions are important in the development of Th2 responses and allergy (93, 94 (45, 99, 100) . Strains which express the active i1 form of VacA are usually also cagA + and those expressing the i2 form of VacA are usually cagA − (101). This was indeed true in 39/49 of our clinical isolates and, since the vacA types also followed the same trend in the IgE data, we consider it likely that the reported stronger protection from CagA + strains against childhood asthma could actually have been driven by VacA, with CagA acting as a marker for this. We previously found elevated IL-10 responses in the cagA + -infected gastric mucosa (48) , but in the present study, we could not find a corresponding significant difference in the peripheral blood (data not shown). It has been suggested that cagA + strains may elicit an increased gastric Treg response to modulate the heightened inflammation, but that there is also a pronounced effect on the migration of Tregs, which may have an impact on the populations found in peripheral blood (68, 102) .
We performed experiments with an in vitro culture system to investigate the impact of IL-10 and TGFβ on IgE production in a well-controlled manner. The healthy donors who provided us with blood samples did not have different plasma IgE concentrations according to their H. pylori status (data not shown); therefore, these experiments allowed us to investigate the potential for their PBMCs to be influenced by a Th2-skewing treatment and produce IgE in vitro. The cells from the uninfected donors secreted significantly higher IgE concentrations, while producing markedly lower levels of IL-10. This implies that there were marked differences in the PBMC cell populations of infected and uninfected donors and is in agreement with the increased frequencies of IL-10-secreting Tregs among those with H. pylori. When rIL-10 was added to the cultures, in accordance with previous data, the PBMCs produced lower amounts of IgE (76) . This occurred whether the cells were from infected or uninfected donors. When IL-10 blocking antibody was added, however, there was a significantly increased IgE response, which was especially marked when PBMCs were from infected donors. There were minimal effects from rTGFβ1 or TGFβ antibody blockade. These experiments demonstrate the important role of the H. pylori-induced IL-10 response in controlling IgE production. We acknowledge that a weakness in this study comes from the fact that the blood samples did not come from allergic or atopic patients; however, we have gathered some interesting novel data that confirm and extend previous research on this topic. It is not possible to use an in vivo interventional approach in humans to study the role of IL-10 in the protective mechanism behind H. pylori-mediated protection from allergy. Our in vitro culture system provided some important clues, however, and enables us to move the project forward. Since we wish to understand the effects of H. pylori in protection against allergy, the best approach would be to perform an interventional study investigating the effects of antibiotic eradication therapy on allergic parameters and peripheral blood Treg frequencies. This would include looking for differences in IL-10-expressing populations in particular.
In summary, we demonstrated the presence of an increased frequency of regulatory T-cells in the peripheral blood of H. pylori-infected individuals. These cells tended to express IL-10, and high-level responses were associated with reduced plasma IgE concentrations. Using an in vitro culture system, we showed for the first time that PBMCs from H. pylori-infected donors had an enhanced ability to minimize IgE responses, acting in part via IL-10 since there was a 50% increase in IgE when IL-10 was blocked. Further in vitro work (not shown) found that CD4 +
CD25
hi cells, purified from PBMCs of infected and uninfected donors using magnetic bead separation, were able to suppress proliferation and IFNγ production by CD4 + CD25
effector T cells stimulated with anti-CD3/28 beads. This confirms that the cells have a regulatory function, and we are currently working to evaluate whether Tregs from infected individuals have any enhancement in suppressive activity. We also aim to carry out further experiments to elucidate the mechanisms, investigating the types of Tregs responsible (e.g., Tr1 and FOXA1 + cells), and are planning to investigate whether H. pylori exerts a long-lasting influence on the Treg and IL-10 response from early life, or if the immunological effects require continual life-long presence of the infection in the gastric mucosa. Understanding these concepts is going to be of paramount importance, considering the diminishing prevalence of H. pylori around the world, and newly reported hopes for an effective vaccine (103, 104) .
